Rezaei N - Search Results

1

Radioimmunotherapy-based conditioning regimen prior to autologous stem cell transplantation in non-Hodgkin lymphoma.

Eskian M, Khorasanizadeh M, Isidori A, Rezaei N. Eskian M, et al. Among authors: rezaei n. Int J Hematol Oncol. 2018 Jun 13;7(1):IJH01. doi: 10.2217/ijh-2017-0025. eCollection 2018 Mar. Int J Hematol Oncol. 2018. PMID: 30302233 Free PMC article. Review.

2

Efficacy and Safety of Benralizumab, a Monoclonal Antibody against IL-5Rα, in Uncontrolled Eosinophilic Asthma.

Khorasanizadeh M, Eskian M, Assa'ad AH, Camargo CA Jr, Rezaei N. Khorasanizadeh M, et al. Among authors: rezaei n. Int Rev Immunol. 2016 Jul 3;35(4):294-311. doi: 10.3109/08830185.2015.1128901. Epub 2016 Apr 27. Int Rev Immunol. 2016. PMID: 27119985 Review.

3

Radioimmunotherapy in non-Hodgkin lymphoma: Prediction and assessment of response.

Eskian M, Khorasanizadeh M, Kraeber-Bodere F, Rezaei N. Eskian M, et al. Among authors: rezaei n. Crit Rev Oncol Hematol. 2016 Nov;107:182-189. doi: 10.1016/j.critrevonc.2016.10.005. Epub 2016 Oct 13. Crit Rev Oncol Hematol. 2016. PMID: 27823646 Review.

4

Mitogen-activated protein kinases as therapeutic targets for asthma.

Khorasanizadeh M, Eskian M, Gelfand EW, Rezaei N. Khorasanizadeh M, et al. Among authors: rezaei n. Pharmacol Ther. 2017 Jun;174:112-126. doi: 10.1016/j.pharmthera.2017.02.024. Epub 2017 Feb 14. Pharmacol Ther. 2017. PMID: 28223227 Review.

5

Reductions in Eosinophil Biomarkers by Benralizumab in Patients With Asthma.

Khorasanizadeh M, Eskian M, Rezaei N. Khorasanizadeh M, et al. Among authors: rezaei n. Acta Med Iran. 2017 May;55(5):352-353. Acta Med Iran. 2017. PMID: 28724278 Free article. No abstract available.

6

Monoclonal Antibodies for Treatment of Eosinophilic Esophagitis.

Eskian M, Khorasanizadeh M, Assa'ad AH, Rezaei N. Eskian M, et al. Among authors: rezaei n. Clin Rev Allergy Immunol. 2018 Aug;55(1):88-98. doi: 10.1007/s12016-017-8659-7. Clin Rev Allergy Immunol. 2018. PMID: 29234969 Review.

7

Basic understanding and therapeutic approaches to target toll-like receptors in cancerous microenvironment and metastasis.

Khajeh Alizadeh Attar M, Anwar MA, Eskian M, Keshavarz-Fathi M, Choi S, Rezaei N. Khajeh Alizadeh Attar M, et al. Among authors: rezaei n. Med Res Rev. 2018 Sep;38(5):1469-1484. doi: 10.1002/med.21480. Epub 2017 Dec 28. Med Res Rev. 2018. PMID: 29283184 Review.

8

Radioimmunotherapy as the first line of treatment in non-Hodgkin lymphoma.

Eskian M, Khorasanizadeh M, Zinzani PL, Rezaei N. Eskian M, et al. Among authors: rezaei n. Immunotherapy. 2018 Jun;10(8):699-711. doi: 10.2217/imt-2017-0169. Epub 2018 Mar 23. Immunotherapy. 2018. PMID: 29569511 Review.

9

Effect of blood glucose level on standardized uptake value (SUV) in ¹⁸F- FDG PET-scan: a systematic review and meta-analysis of 20,807 individual SUV measurements.

Eskian M, Alavi A, Khorasanizadeh M, Viglianti BL, Jacobsson H, Barwick TD, Meysamie A, Yi SK, Iwano S, Bybel B, Caobelli F, Lococo F, Gea J, Sancho-Muñoz A, Schildt J, Tatcı E, Lapa C, Keramida G, Peters M, Boktor RR, John J, Pitman AG, Mazurek T, Rezaei N. Eskian M, et al. Among authors: rezaei n. Eur J Nucl Med Mol Imaging. 2019 Jan;46(1):224-237. doi: 10.1007/s00259-018-4194-x. Epub 2018 Oct 22. Eur J Nucl Med Mol Imaging. 2019. PMID: 30350009

10

Roles of Myeloid-Derived Suppressor Cells in Cancer Metastasis: Immunosuppression and Beyond.

Pastaki Khoshbin A, Eskian M, Keshavarz-Fathi M, Rezaei N. Pastaki Khoshbin A, et al. Among authors: rezaei n. Arch Immunol Ther Exp (Warsz). 2019 Apr;67(2):89-102. doi: 10.1007/s00005-018-0531-9. Epub 2018 Nov 2. Arch Immunol Ther Exp (Warsz). 2019. PMID: 30386868 Free article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,662 results

Search Page

Filters